Journal of Clinical Nuclear Medicine Publishes Results of Tiziana's Nasal Foralumab in Study Treating Moderate Alzheimer's Disease GlobeNewswire May 15, 2025 NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully […]

ATLANTA, May 15, 2025 (GLOBE NEWSWIRE) — Verusen, the industry leader driving AI for MRO (maintenance, repair, and operations) supply chain and inventory optimization, today launched its groundbreaking Explainability AI Agent for data and context-driven material and inventory optimization. This first-of-its-kind capability delivers unprecedented transparency into Verusen's stocking policy recommendations, enabling procurement, operations, and supply

NEO Battery Appoints Ex-Samsung Large-Scale Cell Expert, Dr. Jun Sik Jeoung, as Senior Scientific Advisor of Commercialization & Cell Development GlobeNewswire May 15, 2025 Appointed Dr. Jun Sik Jeoung as Senior Scientific Advisor of Commercialization & Cell Development Over 17 Years of Experience in Lithium-Ion Battery R&D, Scale-Up, and Production at Global Battery Cell Manufacturers

COLORADO SPRINGS, Colo., May 15, 2025 (GLOBE NEWSWIRE) — BombBomb, the video messaging company for sales professionals, announces the launch of Engage, an enterprise-class platform designed to help sales pros cut through inbox noise with face-to-face video. The sales landscape is undergoing a rapid transformation, especially for B2B, driven by shifting buyer behaviors, longer sales

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates GlobeNewswire May 15, 2025 NEW YORK and MELBOURNE, Australia, May 15, 2025 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex), a clinical-stage biopharmaceutical company leading the way in developing oral combination medicines, today reported fiscal second quarter financial results and provided

(Paris:PUB), Publicis Closed Door Sessions return to Cannes, Helping Clients Create AI Upside to fight the downturn 15th May, 2025 – Paris – Publicis Groupe [Euronext Paris FR0000130577, CAC 40] today announced its Cannes Closed Door Sessions are back, with a new mission: unlocking real – and immediate – AI upside for clients, in an

Immutep's Efti with KEYTRUDA(R) (pembrolizumab) & Chemotherapy Achieves High Response Rates in First-Line Non-Small Cell Lung Cancer GlobeNewswire May 15, 2025 Novel combination achieves 60.8% response rate and 90.2% disease control rate in first-line non-small cell lung cancer (1L NSCLC) Notably, ~92% of all evaluable patients have PD-L1 TPS <50%, including 43% with PD-L1 below

Canadian Students Illuminate Nation's Energy Future Energy Creates Awards Up to $500,000 in Scholarships; Another Half-Million Available in 2025 GlobeNewswire May 15, 2025 CALGARY, Alberta, May 15, 2025 (GLOBE NEWSWIRE) — As the federal government pledges to position Canada as a global energy superpower, five young Canadians are already leading the charge. Through the national

Merus Announces the Journal Publication of Petosemtamab Mechanism of Action GlobeNewswire May 15, 2025 UTRECHT, The Netherlands and CAMBRIDGE, Mass., May 15, 2025 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, “the Company”, “we”, or “our”), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics(R), Triclonics(R) and ADClonics(R)), today announced publication

Christophe Girardier, CEO of Glimpact, to Speak at Three Public Events During hub.brussels' Impact Mission 2025 in New York GlobeNewswire May 15, 2025 NEW YORK, May 15, 2025 (GLOBE NEWSWIRE) — Christophe Girardier, CEO of Glimpact the first platform for analyzing the overall systemic environmental impact of products and organizations, will speak at three public